[Activation of nuclear factor-κB subunit p50/p65 enhances gefitinib resistance of lung adenocarcinoma H1650 cell line]. [electronic resource]
Producer: 20190204Description: 584-590 p. digitalISSN:- 1673-4254
- Adenocarcinoma of Lung -- drug therapy
- Antineoplastic Agents -- pharmacology
- Cell Line, Tumor
- Cell Survival -- drug effects
- Drug Resistance, Neoplasm -- drug effects
- Gefitinib -- pharmacology
- Humans
- NF-kappa B p50 Subunit -- metabolism
- Proline -- analogs & derivatives
- Thiocarbamates -- pharmacology
- Transcription Factor RelA -- metabolism
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.